|
|
|
Volumn 33, Issue 1, 1996, Pages 1-8
|
|
Oral iron chelation
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
CHELATING AGENT;
DEFERIPRONE;
FERRITIN;
IRON;
PENTETIC ACID;
ADOLESCENT;
ADULT;
AGRANULOCYTOSIS;
ANEMIA;
ANIMAL MODEL;
ARTHROPATHY;
BLOOD TRANSFUSION;
CHILD;
CLINICAL ARTICLE;
CLINICAL TRIAL;
DRUG EFFICACY;
FEMALE;
FERRITIN BLOOD LEVEL;
GASTROINTESTINAL SYMPTOM;
HUMAN;
INTRAMUSCULAR DRUG ADMINISTRATION;
IRON CHELATION;
IRON OVERLOAD;
LIVER FUNCTION TEST;
LIVER TOXICITY;
MALE;
MOUSE;
MULTICENTER STUDY;
NONHUMAN;
ORAL DRUG ADMINISTRATION;
PHASE 1 CLINICAL TRIAL;
PHASE 2 CLINICAL TRIAL;
PRIORITY JOURNAL;
RAT;
REVIEW;
SUBCUTANEOUS DRUG ADMINISTRATION;
THALASSEMIA MAJOR;
TREATMENT OUTCOME;
ZINC DEFICIENCY;
ADMINISTRATION, ORAL;
AGRANULOCYTOSIS;
CLINICAL TRIALS;
HUMANS;
IRON CHELATING AGENTS;
JOINT DISEASES;
LIVER FUNCTION TESTS;
PYRIDONES;
ZINC;
|
|
EID: 0030056326
PISSN: 00371963
EISSN: None
Source Type: Journal
DOI: None Document Type: Review |
|
Times cited : (43)
|
|
References (0)
|
